Galien Prize MedStartup

Hemerion awarded the Galien MedStartup Prize

Hemerion and Mount Sinai Health System (NYC) are collaborating to launch an ambitious clinical trial in 2022. This project has won the “Best Collaboration in the MedTech and Digital Health” award of the Galien Medstartup Prize: an international recognition that perfectly kickstarts the Hemerion development in the USA. Read more – Press release

Phase II study granted authorization in Europe

Authorization granted for a phase 2 clinical trial that aims to evaluate the technology developed by Hemerion. This study sponsored by Lille University Hopital (France) is multicentric with additional investigative center in Brussels (Erasme Hospital – Belgium).

Hemerion Technology

Hemerion gathers 1.5M€ in funding

For its preliminary funding round, Hemerion gathers 1.5M€ in dilutive and non-dilutive funding to further validate its therapeutic approach.

Hemerion joins Neighborhood

Hemerion joins the Voisin Consulting Neighborhood program, a life science innovation center that offers tailored mentoring, coaching and global access to health tech entrepreneurs.

I-Lab innovation competition

Hemerion is awarded during I-Lab innovation competition and granted to upgrade its lead product and better meet neurosurgeons needs.